Related Experiment Video
Updated: Feb 10, 2026
RNAi Screening to Identify Postembryonic Phenotypes in C. elegans
Published on: February 13, 2012
A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal
Smitha Kota1, Shurong Hou1, William Guerrant1
1Department of Molecular Medicine, The Scripps Research Institute, Florida, USA.
Abstract:
The RAS proteins are the most frequently mutated oncogenes in cancer, with highest frequency found in pancreatic, lung, and colon tumors. Moreover, the activity of RAS is required for the proliferation and/or survival of these tumor cells and thus represents a high-value target for therapeutic development. Direct targeting of RAS has proven challenging for multiple reasons stemming from the biology of the protein, the complexity of downstream effector pathways and upstream regulatory networks. Thus, significant efforts have been directed at identifying downstream targets on which RAS is dependent. These efforts have proven challenging, in part due to confounding factors such as reliance on two-dimensional adherent monolayer cell cultures that inadequately recapitulate the physiologic context to which cells are exposed in vivo. To overcome these issues, we implemented a high-throughput screening (HTS) approach using a spheroid-based 3-dimensional culture format, thought to more closely reflect conditions experienced by cells in vivo. Using isogenic cell pairs, differing in the status of KRAS, we identified Proscillaridin A as a selective inhibitor of cells harboring the oncogenic KRasG12V allele. Significantly, the identification of Proscillaridin A was facilitated by the 3D screening platform and would not have been discovered employing standard 2D culturing methods.
Insights
Researchers discovered Proscillaridin A, a potential cancer drug, using advanced 3D cell cultures. This new method effectively identifies KRAS inhibitors, overcoming limitations of traditional 2D cell studies for cancer therapy development.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- RAS proteins are frequently mutated oncogenes in cancers like pancreatic, lung, and colon tumors.
- RAS activity is crucial for tumor cell proliferation and survival, making it a key therapeutic target.
- Directly targeting RAS is difficult due to its complex biology and regulatory networks.
Purpose of the Study:
- To identify novel downstream targets dependent on RAS activity for cancer cell survival.
- To overcome limitations of 2D cell culture models in recapitulating in vivo physiological conditions.
Main Methods:
- Implemented a high-throughput screening (HTS) approach utilizing spheroid-based 3-dimensional (3D) cell cultures.
- Employed isogenic cell pairs differing in KRAS mutation status for comparative analysis.
- Utilized 3D culture systems to more accurately model in vivo cellular environments.
Main Results:
- Identified Proscillaridin A as a selective inhibitor of cancer cells with the oncogenic KRasG12V mutation.
- The discovery of Proscillaridin A was critically dependent on the 3D screening platform.
- Standard 2D culturing methods would not have led to the identification of Proscillaridin A.
Conclusions:
- 3D spheroid-based culture systems provide a more physiologically relevant platform for cancer drug discovery.
- Proscillaridin A is a promising therapeutic candidate for cancers harboring the KRasG12V mutation.
- Advanced screening methods are essential for identifying novel cancer therapeutics targeting complex oncogenic pathways.
Related Concept Videos
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:21Frequency-dependent Selection
03:40Dimensional Analysis
Conversion Factors and Dimensional Analysis
The unit...
01:32What is Natural Selection?
00:57Antibiotic Selection
01:46Types of Selection